Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ABBOTT LABORATORIES ABT

Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the... see more

Recent & Breaking News (NYSE:ABT)

Abbott to Present at Cowen and Company 35th Annual Health Care Conference

PR Newswire February 19, 2015

Abbott to Present at Leerink Global Healthcare Conference

PR Newswire February 4, 2015

Insulet Extends Exclusive Agreement for Blood Glucose Monitoring

Marketwired February 3, 2015

Abbott Launches New Options for People with Cataracts in the United States

PR Newswire January 30, 2015

Mylan Shareholders Overwhelmingly Approve Agreement Implementing Acquisition of Abbott's Non-U.S. Developed Markets Specialty and Branded Generics Business

PR Newswire January 29, 2015

Abbott Reports Fourth-Quarter 2014 Results

PR Newswire January 29, 2015

Abbott Announces Results of Tender Offer and Consent Solicitation for CFR International SpA 5.125% Senior Notes due 2022

PR Newswire January 15, 2015

Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2014 Earnings

PR Newswire January 8, 2015

Abbott Announces Early Results of Tender Offer and Consent Solicitation for CFR International SpA 5.125% Senior Notes due 2022

PR Newswire December 30, 2014

Abbott Completes Acquisition of Topera, Inc.

PR Newswire December 22, 2014

Abbott to Present at J.P. Morgan Healthcare Conference

PR Newswire December 18, 2014

Older Relatives At Risk of Malnutrition - How To Spot The Signs As Families Gather This Christmas

PR Newswire December 15, 2014

Abbott Commences Tender Offer and Consent Solicitation for CFR International SpA 5.125% Senior Notes due 2022

PR Newswire December 15, 2014

Abbott Announces Increase in Quarterly Dividend

PR Newswire December 12, 2014

Abbott Completes Acquisition of Veropharm

PR Newswire December 12, 2014

Abbott's Pioneering, Infectious Disease Testing Platform, IRIDICA, Now Available in Europe

PR Newswire December 11, 2014

Impact of Malnutrition in U.S. at $157 Billion Annually

PR Newswire December 4, 2014

Australian Diabetes Management Market and Diabetes Diagnostic Devices Market Spurted by $46 Million Between 2005 and 2013

PR Newswire December 1, 2014

People with Chronic Obstructive Pulmonary Disease (COPD) Who Received Nutrition Treatment in the Hospital Had Better Health Outcomes

PR Newswire November 17, 2014

Abbott to Present at Credit Suisse 2014 Healthcare Conference

PR Newswire November 4, 2014